Characterization of six CaMKIIα variants found in patients with schizophrenia
Authors:
Open Access
- 27 September 2021
- Vol. 24 (10) , 103184
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01AG067713)
- National Institutes of Health (F31AG062160)
- National Institutes of Health (T32GM007635)
- National Institutes of Health (P30 NS048154)
- National Institutes of Health (R01NS081248)
- National Institutes of Health (P30 DK116073)
This publication has 60 references indexed in Scilit:
- Recombinant Probes for Visualizing Endogenous Synaptic Proteins in Living NeuronsNeuron, 2013
- CaMKII binding to GluN2B is critical during memory consolidationThe EMBO Journal, 2012
- De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophreniaMolecular Psychiatry, 2011
- Deletion of Densin-180 Results in Abnormal Behaviors Associated with Mental Illness and Reduces mGluR5 and DISC1 in the Postsynaptic Density FractionJournal of Neuroscience, 2011
- Improving a Natural CaMKII Inhibitor by Random and Rational DesignPLOS ONE, 2011
- The treatment of cognitive impairment in schizophreniaPharmacology Biochemistry and Behavior, 2011
- CaMKII Autonomy Is Substrate-dependent and Further Stimulated by Ca2+/CalmodulinJournal of Biological Chemistry, 2010
- Autophosphorylation of αCaMKII is differentially involved in new learning and unlearning mechanisms of memory extinctionLearning & Memory, 2008
- Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disordersMolecular Brain, 2008
- Starting at the endophenotype: A role for alpha-CaMKII in schizophrenia?Molecular Brain, 2008